Nationwide cohort of elderly patients with coronary heart disease in China
Seniors Integrated Longitudinal cardioVascular Evaluation of Coronary Heart Disease: a Multicenter, Prospective Registry in China (SILVER-China)
This study is trying to gather health information from older patients with coronary heart disease in China to help improve their treatment and predict their health risks better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10139 (estimated) |
| Ages | 75 Years and up |
| Sex | All |
| Sponsor | Beijing Hospital Government |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Trial ID | NCT06880575 on ClinicalTrials.gov |
What this trial studies
This study aims to create a comprehensive cohort and biobank of elderly patients suffering from coronary heart disease (CHD) across 50 hospitals in China. It will utilize electronic data collection to gather extensive demographic, clinical, lifestyle, and biological information from participants aged 75 and older. The goal is to develop risk prediction models and optimize clinical treatment plans based on the collected data, with long-term follow-up assessments at various intervals.
Who should consider this trial
Good fit: Ideal candidates for this study are elderly individuals aged 75 and older who have been hospitalized due to symptoms related to coronary heart disease.
Not a fit: Patients with severe non-cardiovascular diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved risk assessment and treatment strategies for elderly patients with coronary heart disease.
How similar studies have performed: Other studies focusing on elderly populations with coronary heart disease have shown promise, indicating that this approach could yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria:
① Age requirements: Participants are ≥ 75 years old;
* This time he was admitted to the hospital due to angina pectoris and other coronary heart disease-related symptoms
③ Conform to the diagnosis of coronary heart disease: meet any one of the following conditions:
1. This admission was performed for coronary angiography, coronary artery CTA confirmed coronary heart disease;
2. Previous clear coronary angiography, coronary artery Coronary heart disease diagnosed by imaging evidence such as CTA evidence;
3. The attending physician according to the patient's symptoms, medical history, myocardial injury markers, electrocardiogram, echo cardiography, myocardial radionuclide imaging, etc. diagnosed coronary heart disease.
④ Informed consent: Participants must be able to understand the content of the study, voluntarily participate in the study, and sign the informed consent form.
Exclusion Criteria:
* Combined with severe non-cardiovascular disease: life expectancy does not exceed 6 months, such as advanced cancer or other end-stage disease;
* Unable to cooperate with long-term follow-up: such as patients with severe cognitive impairment or severe mental illness; ③ Non-cardiogenic death within 24 hours after admission.
Where this trial is running
Beijing, Beijing Municipality
- Beijing Hospital — Beijing, Beijing Municipality, China (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.